吴国敏,史珂蔓,刘娟,冯玲,杨宇石,李珀,徐澍
WU Guomin,SHI Keman,LIU Juan,FENG Ling,YANG Yushi,LI Po,XU Shu

• 1:贵州医科大学口腔医学院口腔组织病理学教研室
• 2:贵州医科大学临床医学院病理学教研室

摘要(Abstract)：

目的:探讨人脑胶质瘤组织中磷脂酰肌醇3'-激酶(PI3K)信号通路的关键信号分子激酶B(AKT)和雷帕霉素靶蛋白(m TOR)在人脑胶质瘤中的表达及意义。方法:收集45例胶质瘤患者的临床资料和病理诊断存档蜡块,同时收集同期25例其他非肿瘤病变的脑血管疾病患者的脑组织存档蜡块为对照组;采用免疫组织化学链霉菌抗生物素蛋白—过氧化物酶法(SP法)检测AKT及m TOR蛋白的表达,应用EXCEL、SPSS 25. 0统计软件分析AKT及m TOR蛋白与胶质瘤患者临床病理特征的关系。结果:实验组脑组织细胞AKT及m TOR蛋白阳性表达率均高于对照组,差异有统计学意义(P <0. 05);实验组AKT和m TOR存在显著正相关关系(r=0. 448,P <0. 01),不同性别、年龄、肿瘤发生部位及病理分级与AKT及m TOR蛋白阳性表达率之间比较,差异均无统计学意义(P> 0. 05)。结论:PI3K信号通路的关键信号分子AKT及m TOR在脑胶质瘤组织中存在过表达现象,但该表达与胶质瘤患者的临床病理特征无关。
Objective: To investigate the expression of key signaling molecular kinase B( AKT) and rapamycin target( m TOR) proteins in phosphatidylinositol 3 '-kinase( PI3 K) signaling pathway in human glioma tissues. Methods: Clinical data and pathological diagnosis of 45 patients with glioma were collected. At the same time,25 patients with other non-tumor cerebrovascular diseases were collected as control group. The expression of AKT and m TOR proteins was detected by the( SP)method of immunohistochemical streptomyces biotin-peroxidase. The relationship between AKT and m TOR proteins and clinicopathological features of glioma patients were analyzed by using EXCEL and SPSS 25. 0 statistical software. Results: The expression rates of AKT and m TOR protein in brain tissue cells were higher than those in control group,and the difference was statistically significant( P <0. 05). There was significant positive correlation between AKT and m TOR in experimental group( r =0. 448,P < 0. 01). There was no significant difference in sex, age, tumor location, and the comparison of pathological grade,AKT,and expression rate of m TOR protein positive( P > 0. 05).Conclusion: The key signal molecular AKT and m TOR of PI3 K signaling pathway are overexpressed in glioma tissue, but this expression is independent of clinicopathological characteristics of glioma patients.

关键词(KeyWords)： 神经胶质瘤;免疫组织化学;PI3K信号通路;AKT;雷帕霉素靶蛋白
glioma;immunohistochemistry;PI3K signaling pathway;AKT;m TOR

Abstract:

Keywords:

基金项目(Foundation): 贵阳市科技局项目[筑科合(20161001)43];; 贵州省科技厅联合资金项目[黔科合LH字(2016)7241]

作者(Author): 吴国敏,史珂蔓,刘娟,冯玲,杨宇石,李珀,徐澍
WU Guomin,SHI Keman,LIU Juan,FENG Ling,YANG Yushi,LI Po,XU Shu

DOI: 10.19367/j.cnki.2096-8388.2020.12.011

参考文献(References)：

• [1]何洁，张大鹏，何静．替莫唑胺对比传统化疗药治疗高级别脑胶质瘤的临床疗效[J]．现代肿瘤医学，2015(17):2420-2423.
• [2] LU Y J,XIA X S,HEMATOLOGY D. Correlation of PI3K/AKT signaling pathway with cell apoptosis and invasion in mantle cell lymphoma[J]. Journal of Hainan Medical University,2017,23(16):102-105.
• [3]TENG H,LIJIE Z,LONGWANG W,et al. CLCA4 inhibits bladder cancer cell proliferation,migration,and invasion by suppressing the PI3K/AKT pathway[J]. Oncotarget,2017,8(54):93001-93013.
• [4]中华医学会病理学分会脑神经病理学组．2016 WHO中枢神经系统肿瘤分类第4版修订版概述及胶质瘤部分介绍[J]．中华病理学杂志，2016,45(11):745-747.
• [5]许良中，杨文涛．免疫组织化学反应结果的判断标准[J]．中国癌症杂志，1996,6(4):229-231.
• [6]JIE X,XIYAN W,HUI G E,et al. Cx32 mediates norepinephrine-promoted EGFR-TKI resistance in a gap junction-independent manner in non-small-cell lung cancer[J]. Journal of Cellular Physiology,2019,234(12):23146-23159.
• [7]MENG Z,QING C,XIAO Y Z,et al. Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation[J]. Journal of Cellular Physiology,2019,234(5):6361-637.
• [8]WES S P,VAN D B,PERRY A. Oligodendroglioma:Pathology,molecular mechanisms and markers[J]. Acta Neuropathol,2015,129(6):809-827.
• [9]WANG W F,XIE Y,ZHOU Z H,et al. PIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients[J].Acta Pharmacologica Sinica, 2013, 34(12):1560-1567.
• [10]王卫峰，何靖康，秦正红，等．食管癌组织P110α和p AKT蛋白的表达及其临床意义[J]．中国肿瘤生物治疗杂志，2012,19(5):539-542.
• [11]张浩．PI3K中p110α和p85α亚基在侵袭性和非侵袭性无功能垂体腺瘤中表达特点[D]．北京:北京协和医学院，2015.
• [12]徐余超．PI3K/AKT/m TOR通路关键信号分子在胃癌组织中的表达及意义[D]．南京:东南大学，2017.
• [13]杨满，崔军威，程苒，等．乳腺癌细胞ret基因转录水平的表达及其与PI3KAKTmTOR信号通路相关因子的关系[J]．实用临床医学，2017,18(6):43-45.
• [14]董君，马彬，杨京京，等．结直肠癌中p-AKT和PTEN蛋白的表达及其临床意义[J]临床与理杂志，2010,26(3):316-319.
• [15]刘东刚，白春华，张旭东．PI3K/AKT/MTOR信号通路关键信号分子在胃癌组织中的表达及与临床特征的关系[J]．癌症进展，2018,16(12):70-74.

文章评论(Comment)：